Session 154 - 12th CROI

Home

Session 154 Poster Abstracts
Tuberculosis and HIV
Wednesday, 1:30 - 3:30 pm
Hall B

887	A Clinical Prediction Rule to Identify High-risk Cases for HIV Co-infection among Patients Presenting with Tuberculosis S K Sharma*, T Kadhiravan, A Banga, and P Saha All India Inst of Med Sci, New Delhi, India
888	Comparison of the Sensitvity of an in-Tube, Whole Blood, Inteferon-g Release Assay using ESAT-6 and CFP-10 to Sputum Smear Results in HIV-infected Patients with Pulmonary Tuberculosis Simon Tsiouris*¹, P Toro¹, J Austin¹, D Coetzee², Z Stein¹, and W El-Sadr¹ ¹Columbia Univ, New York, NY, USA and ²Univ of Cape Town, South Africa
889	Clinical Usefulness of Spoligotyping, a Molecular Method for Simultaneous Identification and Typing of Mycobacterium tuberculosis Lidia Gazzola*¹, A Gori¹, A Bandera¹, G Marchetti¹, A Degli Esposti¹, L Catozzi¹, G Nardi², G Ferrario¹, F Zanini¹, J van Embden³, D van Soolingen³, M Moroni¹, and F Franzetti¹ ¹Univ of Milan, Italy; ²Laboratory of Microbiology, Luigi Sacco Hospital, Milan, Italy; and ³Natl Inst of Publ Hlth and Environmental Protection (RIVM), Bilthoven, The Netherlands
890	Optimal Timing of Administration of ART in AIDS Patients with Tuberculosis Santiago Moreno*¹, J Oliva¹, E Navas¹, P Miralles¹, J González², R Rubio³, F Pulido³, E Valencia⁴, A Arranz⁵, and J Sanz⁵ ¹Hosp Ramon y Cajal, Madrid, Spain; ²Hosp La Paz, Madrid, Spain; ³Hosp 12 de Octubre, Madrid, Spain; ⁴Hosp Carlos III, Madrid, Spain; and ⁵Hosp Principe de Asturias, Madrid, Spain
891	Efavirenz Levels and Clinical Outcomes in Patients with TB and HIV Treated Concomitantly with ART and Rifampin-containing TB Regimen Gerald Friedland*^1,2, C Jack², S Khoo³, U Lalloo², and V Naidoo² ¹Yale Univ, New Haven, CT, USA; ²Nelson R Mandela Sch of Med, Univ KwaZulu Natal, Durban, South Africa; and ³Univ of Liverpool, UK
892	IL-15 Adjuvants T-cell Responses in vivo to a Multi-epitope DNA Vaccine against Mtb Luisa Marcon*¹, J McMurry¹, J Franco¹, J Carter², M Gennaro³, W Martin⁴, and A DeGroot¹ ¹Brown Univ Sch of Med, Providence, RI, USA; ²Rhode Island TB Clinic, Providence, USA; ³Publ Hlth Res Inst, New York, NY, USA; and ⁴EpiVax, Providence, RI, USA